Eli Lilly Expands Vaccine Push With Deals Worth Up To $3.8B
Eli Lilly and Co. said Tuesday it will buy three companies involved in vaccine development — Curevo Inc., LimmaTech Biologics AG, and Vaccine Company Inc. — for a total of up to...To view the full article, register now.
Already a subscriber? Click here to view full article